Background: In patients with atherosclerotic cardiovascular disease (ASCVD), the relationship of lipoprotein(a) [Lp(a)] levels with ASCVD outcomes when LDL-C levels are controlled remains unclear. Methods: We studied 3,196 patients with… Click to show full abstract
Background: In patients with atherosclerotic cardiovascular disease (ASCVD), the relationship of lipoprotein(a) [Lp(a)] levels with ASCVD outcomes when LDL-C levels are controlled remains unclear. Methods: We studied 3,196 patients with ASCVD in the AIM-HIGH trial, all of whom were on statin
               
Click one of the above tabs to view related content.